<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: The Next Fight Over Avandia Is Under Way</title>
	<atom:link href="http://www.pharmalot.com/2007/08/the-real-fight-over-avandia-is-under-way/feed" rel="self" type="application/rss+xml" />
	<link>http://www.pharmalot.com/2007/08/the-real-fight-over-avandia-is-under-way/</link>
	<description>News, Comment and Conversation</description>
	<pubDate>Sat, 20 Mar 2010 00:44:49 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.2</generator>
		<item>
		<title>By: Simon Passanante - Glaxo throws the next punch in fight over Avandia</title>
		<link>http://www.pharmalot.com/2007/08/the-real-fight-over-avandia-is-under-way/#comment-16548</link>
		<dc:creator>Simon Passanante - Glaxo throws the next punch in fight over Avandia</dc:creator>
		<pubDate>Wed, 08 Aug 2007 22:32:09 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2007/08/the-real-fight-over-avandia-is-under-way/#comment-16548</guid>
		<description>[...] Pharmalot reports that Glaxo, the maker of the diabetes drug Avandia, is sending e-mails to different media outlets bragging about a new study published in The Annals of Internal Medicine by George Diamond and Sanjay Kaul of Cedars-Sinai Medical Center in Los Angeles.Â  Their report took aim at a previous meta-analysis published in the New England Journal of Medicine by cardiologist Steve Nissen. [...]</description>
		<content:encoded><![CDATA[<p>[...] Pharmalot reports that Glaxo, the maker of the diabetes drug Avandia, is sending e-mails to different media outlets bragging about a new study published in The Annals of Internal Medicine by George Diamond and Sanjay Kaul of Cedars-Sinai Medical Center in Los Angeles.Â  Their report took aim at a previous meta-analysis published in the New England Journal of Medicine by cardiologist Steve Nissen. [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Tom Lamb</title>
		<link>http://www.pharmalot.com/2007/08/the-real-fight-over-avandia-is-under-way/#comment-16532</link>
		<dc:creator>Tom Lamb</dc:creator>
		<pubDate>Wed, 08 Aug 2007 15:49:34 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2007/08/the-real-fight-over-avandia-is-under-way/#comment-16532</guid>
		<description>Given this mixed set of conclusions reached to date as regards the analysis of Avandia study data currently available, the FDA certainly has a lot to think about concerning this high-profile Avandia drug safety issue.</description>
		<content:encoded><![CDATA[<p>Given this mixed set of conclusions reached to date as regards the analysis of Avandia study data currently available, the FDA certainly has a lot to think about concerning this high-profile Avandia drug safety issue.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Analytical Scientist</title>
		<link>http://www.pharmalot.com/2007/08/the-real-fight-over-avandia-is-under-way/#comment-16518</link>
		<dc:creator>Analytical Scientist</dc:creator>
		<pubDate>Wed, 08 Aug 2007 12:44:48 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2007/08/the-real-fight-over-avandia-is-under-way/#comment-16518</guid>
		<description>Nissen started this all with his media mongering.  He came at Avandia while still coming off a Vioxx high.  In my opinion, he acted precipitously.  If he ends up with egg on his face, he earned it. Ultimatly, the bill will be footed by GSK, though.</description>
		<content:encoded><![CDATA[<p>Nissen started this all with his media mongering.  He came at Avandia while still coming off a Vioxx high.  In my opinion, he acted precipitously.  If he ends up with egg on his face, he earned it. Ultimatly, the bill will be footed by GSK, though.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Steve Woodruff</title>
		<link>http://www.pharmalot.com/2007/08/the-real-fight-over-avandia-is-under-way/#comment-16480</link>
		<dc:creator>Steve Woodruff</dc:creator>
		<pubDate>Tue, 07 Aug 2007 23:34:49 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2007/08/the-real-fight-over-avandia-is-under-way/#comment-16480</guid>
		<description>What's next?...let's have some clinical experts debate both Nissen's approach, and the Cedars-Sinai approach, and see if some kind of truth can be discerned.</description>
		<content:encoded><![CDATA[<p>What&#8217;s next?&#8230;let&#8217;s have some clinical experts debate both Nissen&#8217;s approach, and the Cedars-Sinai approach, and see if some kind of truth can be discerned.</p>
]]></content:encoded>
	</item>
</channel>
</rss>
